Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biotherapy”

319 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 319 results

Not applicableStudy completedNCT04679272
What this trial is testing

Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients

Who this might be right for
Covid19Rheumatoid Arthritis
University Hospital, Montpellier 2,000
Not applicableUnknownNCT05689892
What this trial is testing

Shared Decision Making in Paediatric Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis+1 more
London Health Sciences Centre 150
Not applicableUnknownNCT05767814
What this trial is testing

Optimization of Psoriatic and Seronegative Rheumatoid Arthritis Patients Selection and Treatment Outcomes of Biologic Therapies.

Who this might be right for
Psoriatic ArthritisRheumatoid Arthritis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 135
Post-approval studies (Phase 4)Study completedNCT01593332
What this trial is testing

Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis

Who this might be right for
DMARD Resistant Rheumatoid Arthritis
Mashhad University of Medical Sciences 44
Early research (Phase 1)Study completedNCT00019136
What this trial is testing

Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00615758
What this trial is testing

Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 50
Testing effectiveness (Phase 2)Study completedNCT00005948
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Early research (Phase 1)UnknownNCT02193893
What this trial is testing

Biological Treatment of Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Pomeranian Medical University Szczecin 50
Testing effectiveness (Phase 2)Study completedNCT00004022
What this trial is testing

Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Barbara Ann Karmanos Cancer Institute
Not applicableNot Yet RecruitingNCT07417995
What this trial is testing

Clinical and Immune Responses to Sequential Biologic Therapies in Psoriatic Arthritis

Who this might be right for
Psoriasis Arthritis
Royal United Hospitals Bath NHS Foundation Trust 400
Not applicableStudy completedNCT05957120
What this trial is testing

Subclinical Impairment of Cardiovascular System in Patients With Psoriasis

Who this might be right for
PsoriasisInflammationEndothelial Dysfunction+4 more
University Medical Centre Ljubljana 100
Post-approval studies (Phase 4)Looking for participantsNCT05169593
What this trial is testing

Prevention of Postoperative Endoscopic Recurrence with Endoscopy-driven Versus Systematic Biological Therapy

Who this might be right for
Crohn Disease
Universitaire Ziekenhuizen KU Leuven 292
Post-approval studies (Phase 4)UnknownNCT04895423
What this trial is testing

Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in Childhood

Who this might be right for
Atopic Dermatitis
National Medical Research Center for Children's Health, Russian Federation 160
Testing effectiveness (Phase 2)Study completedNCT01091259
What this trial is testing

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
NYU Langone Health 29
Not applicableStudy completedNCT04903691
What this trial is testing

Changes in Fitness and Strength in Postoperative Cardiac Patients Undergoing Exercise Therapy: Biological and Functional Mechanisms of Recovery

Who this might be right for
Cardiorespiratory; Insufficiency, Due to A Procedure, Long-Term, Cardiac Surgery
Yale University 9
Early research (Phase 1)Ended earlyNCT00003434
What this trial is testing

Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Duke University 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602
What this trial is testing

Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Who this might be right for
Hidradenitis Suppurativa
AbbVie 210
Early research (Phase 1)Study completedNCT02339324
What this trial is testing

Neoadjuvant Combination Biotherapy With Pembrolizumab and High Dose IFN-alfa2b

Who this might be right for
Melanoma
Yana Najjar 31
Testing effectiveness (Phase 2)Study completedNCT01545908
What this trial is testing

Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Hamilton Health Sciences Corporation 130
Very early researchLooking for participantsNCT06765876
What this trial is testing

CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial

Who this might be right for
Leukemia, Myeloid, Acute(AML)Precursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes (MDS)+1 more
Institute of Hematology and Blood Transfusion, Czech Republic 18
Load More Results